MENU
Advertentie
Advertentie
tijdsduur
ca. 1 uur
organisatie
Carcinos
kosten
basistarief
Gratis
extra prijsinformatie
informatie
gebied:
Somatiek, Overig
categorie(ën):
Algemeen & overig
onderwerp(en):
Immunologie/vaccinatie
ICPC:
A
sponsoring
Onbekend
accreditatie
accreditatie
1
punten
abonnement
e
learning
Management of adverse events of immune checkpoint inhibitors in cancer patients
Accreditatie Periode: 13-2-2019 t/m 12-2-2021

This course provides guidance for the management of adverse events of immune checkpoint inhibitors (ICPI) in cancer patients, based upon the ESMO Clinical Practice Guidelines issued in 2017.

After successful completion the participant will be able to:

  • describe the most frequent and most severe types of irAEs induced by ICPIs in cancer patients.
  • assess the risk of irAEs in the light of the potential benefits of ICPI treatment in cancer.
  • recognize signs of irAEs developing in patients treated with ICPIs.
  • implement possible precautions to prevent development or worsening of certain irAEs.
  • manage selected irAEs of ICPIs according to guidelines issued by ESMO.
Hebt u suggesties voor het verbeteren van deze pagina of algemene op- of aanmerkingen met betrekking tot onze website? Laat het ons hier weten!